Kodiak Sciences Statistics
Total Valuation
Kodiak Sciences has a market cap or net worth of $233.63 million. The enterprise value is $109.20 million.
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, after market close.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Kodiak Sciences has 52.50 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Current Share Class | 52.50M |
| Shares Outstanding | 52.50M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.12% |
| Owned by Insiders (%) | 5.55% |
| Owned by Institutions (%) | 45.06% |
| Float | 32.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.42, with a Debt / Equity ratio of 0.40.
| Current Ratio | 8.42 |
| Quick Ratio | 8.22 |
| Debt / Equity | 0.40 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.57% and return on invested capital (ROIC) is -39.56%.
| Return on Equity (ROE) | -78.57% |
| Return on Assets (ROA) | -27.71% |
| Return on Invested Capital (ROIC) | -39.56% |
| Return on Capital Employed (ROCE) | -58.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.73M |
| Employee Count | 111 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.74% in the last 52 weeks. The beta is 2.06, so Kodiak Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | -17.74% |
| 50-Day Moving Average | 7.65 |
| 200-Day Moving Average | 4.45 |
| Relative Strength Index (RSI) | 27.56 |
| Average Volume (20 Days) | 347,151 |
Short Selling Information
The latest short interest is 2.04 million, so 3.88% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 1.71M |
| Short % of Shares Out | 3.88% |
| Short % of Float | 6.32% |
| Short Ratio (days to cover) | 4.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -204.04M |
| Pretax Income | -232.75M |
| Net Income | -191.62M |
| EBITDA | -185.23M |
| EBIT | -204.04M |
| Earnings Per Share (EPS) | -$3.65 |
Full Income StatementBalance Sheet
The company has $197.86 million in cash and $73.44 million in debt, giving a net cash position of $124.43 million or $2.37 per share.
| Cash & Cash Equivalents | 197.86M |
| Total Debt | 73.44M |
| Net Cash | 124.43M |
| Net Cash Per Share | $2.37 |
| Equity (Book Value) | 185.37M |
| Book Value Per Share | 3.53 |
| Working Capital | 178.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$119.49 million and capital expenditures -$27.76 million, giving a free cash flow of -$147.25 million.
| Operating Cash Flow | -119.49M |
| Capital Expenditures | -27.76M |
| Free Cash Flow | -147.25M |
| FCF Per Share | -$2.80 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |